Good Tolerance to Full-Dose Crizotinib in a Patient with Anaplastic Lymphoma Receptor Tyrosine Kinase-Rearranged Lung Adenocarcinoma and Preexisting Renal Impairment

Publisher： Karger

E-ISSN： 1662-6575|10|2|447-451

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.10, Iss.2, 2017-05, pp. : 447-451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Crizotinib Rechallenge after Crizotinib-Induced Organizing Pneumonia in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 681-684

Karger

Access to resources Recommend Favorite

Alectinib-Induced Erythema Multiforme and Successful Rechallenge with Alectinib in a Patient with Anaplastic Lymphoma Kinase-Rearranged Lung Cancer

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-12 ,pp. : 826-832

Karger

Access to resources Recommend Favorite

Successful Management of Crizotinib-Induced Neutropenia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-01 ,pp. : 51-55

Karger

Access to resources Recommend Favorite

A Case of Orbital Metastasis as Disease Progression of Anaplastic Lymphoma Kinase-Positive Lung Cancer Treated with Crizotinib

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-01 ,pp. : 21-24

Karger

Access to resources Recommend Favorite

Disease Flare after Discontinuation of Crizotinib in Anaplastic Lymphoma Kinase-Positive Lung Cancer

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-08 ,pp. : 430-433

Karger

Access to resources Recommend Favorite